Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 34 (6) , 853-858
- https://doi.org/10.1038/ki.1988.260
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Conjugated Estrogens for the Management of Bleeding Associated with Renal FailureNew England Journal of Medicine, 1986
- Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated EstrogensNew England Journal of Medicine, 1985
- Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusionsBritish Journal of Haematology, 1985
- TREATMENT OF URAEMIC BLEEDING WITH CONJUGATED OESTROGENThe Lancet, 1984
- Intranasal Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaAmerican Journal of Nephrology, 1984
- Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaNew England Journal of Medicine, 1983
- URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONSThe Lancet, 1982
- Effect of 1-Deamino-8-D-Arginine Vasopressin on the Prolonged Bleeding Time in Chronic Renal FailureNephron, 1982
- Treatment of the Bleeding Tendency in Uremia with CryoprecipitateNew England Journal of Medicine, 1980
- The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of VarianceJournal of the American Statistical Association, 1937